These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32726003)

  • 1. [Large- scale prospective clinical study on prophylactic intervention of COVID-19 in community population using Huoxiang Zhengqi Oral Liquid and Jinhao Jiere Granules].
    Yan BH; Jiang ZW; Zeng JP; Tang JY; Ding H; Xia JL; Qin SR; Jin SC; Lu Y; Zhang N; Wang ZH; Li HY; Sang XY; Wu LN; Tang SY; Li Y; Tao MY; Wang QL; Wang JD; Xie HY; Chen QY; Yang SW; Hu NS; Yang JQ; Bao XX; Zhang Q; Yang XL; Jiang CY; Luo HY; Cai ZH; Yu SG
    Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(13):2993-3000. PubMed ID: 32726003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
    Wang H; Jin XY; Pang B; Liu CX; Zheng WK; Yang FW; Pang WT; Zhang JH
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1232-1241. PubMed ID: 32281330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial.
    Xiao M; Tian J; Zhou Y; Xu X; Min X; Lv Y; Peng M; Zhang Y; Yan D; Lang S; Zhang Q; Fan A; Ke J; Li X; Liu B; Jiang M; Liu Q; Zhu J; Yang L; Zhu Z; Zeng K; Li C; Zheng Y; Wu H; Lin J; Lian F; Li X; Tong X
    Pharmacol Res; 2020 Nov; 161():105126. PubMed ID: 32781283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].
    Niu M; Wang RL; Wang ZX; Zhang P; Bai ZF; Jing J; Guo YM; Zhao X; Zhan XY; Zhang ZT; Song XA; Qin EQ; Wang JB; Xiao XH
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1213-1218. PubMed ID: 32281327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
    Zhang YS; Cong WH; Zhang JJ; Guo FF; Li HM
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1263-1271. PubMed ID: 32281335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.
    Yang Y; Islam MS; Wang J; Li Y; Chen X
    Int J Biol Sci; 2020; 16(10):1708-1717. PubMed ID: 32226288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on treatment of "cytokine storm" by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway].
    Ren Y; Yao MC; Huo XQ; Gu Y; Zhu WX; Qiao YJ; Zhang YL
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1225-1231. PubMed ID: 32281329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of the Timing of Traditional Chinese Medicine Therapy on the Therapeutic Effect and Prognosis of Severe Coronavirus Disease 2019].
    Zhang A; Li YP; Qiu M; Liu HB; Chen ZP; Wan P; Tao Y; Wang H; Wei DR; Li QT; Qin YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Aug; 42(4):521-530. PubMed ID: 32895105
    [No Abstract]   [Full Text] [Related]  

  • 11. [Analysis of traditional Chinese medicine from patent information sharing platform of coronavirus disease 2019 (COVID-19)].
    Yang KL; Gao Y; Yang FW; Liu M; Shi SZ; Chen YM; Zhang JH; Tian JH
    Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(13):3001-3006. PubMed ID: 32726004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial.
    Zhang C; Li J; Wu Z; Wang H; Que C; Zhao H; Wang G
    Trials; 2020 Jun; 21(1):495. PubMed ID: 32513299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-center, randomized controlled trial by the Integrative Management in Japan for Epidemic Disease (IMJEDI study-RCT) on the use of Kampo medicine, kakkonto with shosaikotokakikyosekko, in mild-to-moderate COVID-19 patients for symptomatic relief and prevention of severe stage: a structured summary of a study protocol for a randomized controlled trial.
    Takayama S; Namiki T; Ito T; Arita R; Nakae H; Kobayashi S; Yoshino T; Ishigami T; Tanaka K; Kainuma M; Nochioka K; Takagi A; Mimura M; Yamaguchi T; Ishii T
    Trials; 2020 Oct; 21(1):827. PubMed ID: 33008479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Traditional Chinese Medicine as the Preventive and Therapeutic Remedy for COVID-19.
    Gasmi A; Tippairote T; Mujawdiya PK; Menzel A; Lysiuk R; Shanaida M; Lenchyk L; Peana M; Bjørklund G
    Curr Med Chem; 2024; 31(21):3118-3131. PubMed ID: 36999715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19).
    Zhang L; Yu J; Zhou Y; Shen M; Sun L
    Am J Chin Med; 2020; 48(4):763-777. PubMed ID: 32349517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.
    Zhang K; Tian M; Zeng Y; Wang L; Luo S; Xia W; Zhang X; Zha Y
    Complement Ther Med; 2020 Aug; 52():102473. PubMed ID: 32951723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19.
    Ni L; Zhou L; Zhou M; Zhao J; Wang DW
    Front Med; 2020 Apr; 14(2):210-214. PubMed ID: 32170559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Exploration on scientific connotation of TCM syndromes and recommended prescriptions against COVID-19 based on TCMTP V2.0].
    Xu HY; Zhang YQ; Qing YW; Zhao HY; Wang P; Liu F
    Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1488-1498. PubMed ID: 32489025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.